A multi-institutional group of researchers led by Children’s Hospital of Philadelphia has linked a strong cancer driver gene to changes in proteins that regulate alternative splicing.

Experts in pediatric heart disease from across the country shared the latest findings from their research at a large national conference hosted by the Cardiac Center at CHOP.

So much of our family morning routines can be stressful with getting dressed, eating and getting out the door in a timely manner. This may sound very similar to the nighttime routine: eating, bathing, getting dressed and going to bed in a timely manner.

Those with Down syndrome have increased joint mobility and laxity. They are able to move at their joints in extreme ways.

All lives are enriched by relationships and interdependence, and the lives of children with disabilities are no different.

Children’s Hospital of Philadelphia (CHOP) today announced receipt of a $750,000 grant through TD Bank’s TD Ready Challenge.

The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.

Jake Orlick, an 11-year-old boy, is fighting a courageous battle against Ewing Sarcoma, a rare form of bone cancer. Our Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, may be on the verge of a breakthrough with a novel new experimental treatment for relapsed Ewing sarcoma.

Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, is set to launch a novel, experimental approach to treating relapsed Ewing sarcoma, as highlighted in this story in the Philadelphia Inquirer.

Children’s Hospital of Philadelphia views diversity as a key driver of achievement, particularly when innovation is critical.